WDR5B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.131620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.669600E-01
Normal-vs-Stage2
4.463800E-01
Normal-vs-Stage3
1.345590E-01
Normal-vs-Stage4
7.095400E-01
Stage1-vs-Stage2
1.513970E-02
Stage1-vs-Stage3
7.088500E-02
Stage1-vs-Stage4
6.537600E-01
Stage2-vs-Stage3
1.475400E-01
Stage2-vs-Stage4
2.782600E-01
Stage3-vs-Stage4
1.837950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.227180E-01
Normal-vs-AfricanAmerican
4.556600E-01
Normal-vs-Asian
4.733200E-01
Caucasian-vs-AfricanAmerican
8.287600E-01
Caucasian-vs-Asian
9.545400E-01
AfricanAmerican-vs-Asian
8.250800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.379200E-01
Normal-vs-Female
2.369400E-01
Male-vs-Female
1.824370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.882200E-01
Normal-vs-Age(41-60Yrs)
3.571800E-01
Normal-vs-Age(61-80Yrs)
4.209600E-01
Normal-vs-Age(81-100Yrs)
4.008400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.625600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.090400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.884400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.970200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.696300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.788800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.859600E-01
Normal-vs-Daily Drinker
3.449200E-01
Normal-vs-Weekly Drinker
3.650200E-01
Normal-vs-Occasional Drinker
2.904400E-01
Normal-vs-Social Drinker
8.092800E-01
Non Drinker-vs-Daily Drinker
4.047400E-01
Non Drinker-vs-Weekly Drinker
7.249600E-01
Non Drinker-vs-Occasional Drinker
1.517410E-01
Non Drinker-vs-Social Drinker
4.753600E-02
Daily Drinker-vs-Weekly Drinker
3.157600E-01
Daily Drinker-vs-Occasional Drinker
7.774800E-01
Daily Drinker-vs-Social Drinker
2.180600E-01
Weekly Drinker-vs-Occasional Drinker
1.107770E-01
Weekly Drinker-vs-Social Drinker
3.719800E-02
Occasional Drinker-vs-Social Drinker
2.659000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.681180E-01
Normal-vs-Grade 2
2.357600E-03
Normal-vs-Grade 3
4.442200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.816800E-01
Grade 1-vs-Grade 3
6.525800E-01
Grade 1-vs-Grade 4
1.681180E-01
Grade 2-vs-Grade 3
2.649600E-01
Grade 2-vs-Grade 4
2.357600E-03
Grade 3-vs-Grade 4
4.442200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.546800E-01
Normal-vs-NonDiabetic
2.095600E-01
Diabetic-vs-NonDiabetic
3.318200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.158000E-01
Normal-vs-NoPancreatitis
4.409400E-01
Pancreatitis-vs-NoPancreatitis
2.866600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.730200E-01
Normal-vs-N1
4.357600E-01
N0-vs-N1
2.004000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.299400E-01
Normal-vs-TP53-NonMutant
4.787600E-01
TP53-Mutant-vs-TP53-NonMutant
6.498400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
